Related Experiment Video
Updated: Aug 16, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Long-term survival in coronary artery bypass grafting surgery depending on the second conduit used
1Department of Cardiac Surgery, "Dedinje" Cardiovascular Institute, Heroja Milana Tepića 1, Belgrade 11000, Serbia.
Insights
Radial artery (RA) grafts show better long-term patency than saphenous vein grafts (SVG) in coronary artery bypass grafting (CABG). However, randomized trials are needed to confirm if RA use improves long-term survival.
Area of Science:
- Cardiovascular Surgery
- Vascular Grafting
- Surgical Outcomes
Background:
- Coronary artery bypass grafting (CABG) often utilizes multiple graft conduits.
- The choice between radial artery (RA) and saphenous vein grafts (SVG) as a secondary conduit remains debated.
- While RA grafts demonstrate superior patency rates over time, their impact on long-term survival is less clear.
Discussion:
- Observational studies suggest a potential mortality benefit with RA use in CABG.
- However, robust evidence from randomized controlled trials (RCTs) is lacking to definitively establish superior survival outcomes for RA versus SVG.
- The ongoing ROMA (RCT) study is expected to provide critical data on this topic.
Key Insights:
- Radial artery grafts exhibit significantly better patency compared to saphenous vein grafts in CABG.
- Current evidence linking RA use to reduced all-cause mortality is primarily from observational studies.
- No randomized controlled trial has yet confirmed a significant survival advantage for RA recipients.
Outlook:
- The results of the ROMA (RCT) study are anticipated to resolve the debate on RA versus SVG for long-term survival in CABG patients.
- Further research will elucidate the definitive role of RA as a second conduit in CABG surgery.
- Establishing the optimal second conduit will enhance patient outcomes and refine surgical practices.
Abstract:
There is still debate whether radial artery (RA) conduits are better grafts then saphenous vein grafts (SVG) as a second conduit in coronary artery bypass grafting (CABG) surgery. Although it has been confirmed that RA grafts have significantly better patency over years, only some observational studies have associated RA use with reduced all-cause mortality. So far, no randomized controlled trial (CRT) has confirmed significantly better survival for RA graft recipients versus SVG recipients. Therefore, we have to wait for the results of the ongoing ROMA (CRT) study, to draw relevant conclusions about the impact of the second graft on long-term survival in patients undergoing CABG surgery.

